Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor

The feasibility of performing broad and deep tumour genome sequencing has shed new light into tumour heterogeneity and provided important insights into the evolution of metastases arising from different clones(1,2). To add an additional layer of complexity, tumour evolution may be influenced by sele...

Descripción completa

Detalles Bibliográficos
Autores principales: Juric, Dejan, Castel, Pau, Griffith, Malachi, Griffith, Obi L., Won, Helen H., Ellis, Haley, Ebbesen, Saya H., Ainscough, Benjamin J., Ramu, Avinash, Iyer, Gopa, Shah, Ronak H., Huynh, Tiffany, Mino-Kenudson, Mari, Sgroi, Dennis, Isakoff, Steven, Thabet, Ashraf, Elamine, Leila, Solit, David B., Lowe, Scott W., Quadt, Cornelia, Peters, Malte, Derti, Adnan, Schegel, Robert, Huang, Alan, Mardis, Elaine R., Berger, Michael F., Baselga, José, Scaltriti., Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326538/
https://www.ncbi.nlm.nih.gov/pubmed/25409150
http://dx.doi.org/10.1038/nature13948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326538/
https://www.ncbi.nlm.nih.gov/pubmed/25409150
http://dx.doi.org/10.1038/nature13948

Ejemplares similares